The stock price of BridgeBio…
The stock price of BridgeBio plunged 15% Thursday on Pfizer’s [...]
“FDA will take swift action…
“FDA will take swift action against companies mass-marketing illegal copycat [...]
Amid the fast-moving rollout of…
Amid the fast-moving rollout of the Wegovy pill, Novo Nordisk [...]
On this week’s “The Top Line,”…
On this week’s “The Top Line,” Fierce’s Andrea Park and [...]
Amgen added to uncertainty…
Amgen added to uncertainty surrounding the OX40 drug class by [...]
The majority of Bristol Myers…
The majority of Bristol Myers Squibb’s $48.2 billion revenue haul [...]
Astellas surpassed market…
Astellas surpassed market expectations in its third-quarter fiscal year 2025 [...]
Bristol Myers Squibb has signed…
Bristol Myers Squibb has signed Kasey Keller for a Breyanzi [...]
Charles River Laboratories is…
Charles River Laboratories is continuing its run of layoffs by [...]
As top-selling Keytruda inches…
As top-selling Keytruda inches closer to its 2028 patent cliff, [...]